OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy
Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2535-2535
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He, Lu Zheng, Chunjian Qi
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

EGFR-Targeted Photodynamic Therapy
Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 241-241
Open Access | Times Cited: 64

Dual-Emitter Graphene Glass Fiber Fabric for Radiant Heating
Hao Yuan, Hui Zhang, Kewen Huang, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 2577-2584
Closed Access | Times Cited: 52

High‐Entropy Engineering for Broadband Infrared Radiation
Weiming Wang, Baohua Liu, Cheng‐Yu He, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 43
Closed Access | Times Cited: 29

Bioorthogonally Assisted Phototherapy: Recent Advances and Prospects
Eszter Kozma, Márton Bojtár, Péter Kele
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 33
Open Access | Times Cited: 25

Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity
Masaaki Akai, Kazuhiro Noma, Takuya Kato, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 10, pp. 1647-1658
Open Access | Times Cited: 12

DNA and Nanomaterials: A Functional Combination for DNA Sensing
Mohzibudin Z. Quazi, Jang Hyeon Choi, Min‐Chul Kim, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 2, pp. 778-786
Closed Access | Times Cited: 8

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 11, pp. 1386-1397
Open Access | Times Cited: 35

Supramolecular cancer photoimmunotherapy based on precise peptide self-assembly design
Yamei Liu, Lu Zhang, Rui Chang, et al.
Chemical Communications (2022) Vol. 58, Iss. 14, pp. 2247-2258
Closed Access | Times Cited: 33

Tumor-microenvironment-responsive poly-prodrug encapsulated semiconducting polymer nanosystem for phototherapy-boosted chemotherapy
Jianwei Zhu, Yuning Zhang, Zheng Li, et al.
Materials Horizons (2023) Vol. 10, Iss. 8, pp. 3014-3023
Closed Access | Times Cited: 19

Redox-activated photosensitizers for visualizing precise diagnosis and potentiating cancer therapy
Shuwen Fu, Zixuan Chen, Li Li, et al.
Coordination Chemistry Reviews (2024) Vol. 507, pp. 215734-215734
Closed Access | Times Cited: 7

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
Justyna Mączyńska, Florian Raes, Chiara Da Pieve, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25

Phototherapy: A Conventional Approach to Overcome the Barriers in Oncology Therapeutics
Mohzibudin Z. Quazi, Joonyoung Park, Nokyoung Park
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 15

Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas
Hiroyuki Suzuki, Kazuki Ozawa, Tomohiro Tanaka, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1099-1099
Open Access | Times Cited: 14

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models
Takuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2262-2273
Open Access | Times Cited: 26

Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts
Takuya Kato, Aki Furusawa, Ryuhei Okada, et al.
Molecular Cancer Therapeutics (2022) Vol. 22, Iss. 1, pp. 75-88
Open Access | Times Cited: 16

Targeted Nanophotoimmunotherapy Potentiates Cancer Treatment by Enhancing Tumor Immunogenicity and Improving the Immunosuppressive Tumor Microenvironment
Kunwei Li, Dan Yang, Dechun Liu
Bioconjugate Chemistry (2023) Vol. 34, Iss. 2, pp. 283-301
Closed Access | Times Cited: 10

Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9190-9190
Open Access | Times Cited: 3

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
Hiroshi Fukushima, Barış Türkbey, Peter A. Pinto, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2996-2996
Open Access | Times Cited: 15

Near‐infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab‐IR700
Seiichiro Takao, Hiroshi Fukushima, Anna King, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4654-4663
Open Access | Times Cited: 8

Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond
Danfeng Wei, Jinxin Qi, Michael R. Hamblin, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 7108-7131
Open Access | Times Cited: 13

Near-infrared photoimmunotherapy and anti-cancer immunity
Kohei Nakajima, Mikako Ogawa
International Immunology (2023) Vol. 36, Iss. 2, pp. 57-64
Open Access | Times Cited: 7

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 12, pp. 2869-2879
Open Access | Times Cited: 12

Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy
Zheng Peng, Xiaolan Lv, Shigao Huang
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top